Literature DB >> 16306775

TPMT genotype screening for patients about to begin azathioprine treatment--a look at costs and potential benefits.

Dawn Provenzale1, Jane E Onken.   

Abstract

Entities:  

Year:  2005        PMID： 16306775     DOI： 10.1097/01.mib.0000186491.43191.0e

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  2 in total

1.  Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A.

Authors:  Pooja Budhiraja; Mordecai Popovtzer
Journal:  Nat Rev Nephrol       Date:  2011-06-28       Impact factor: 28.314

2.  Cost-effectiveness analysis of genotype screening and therapeutic drug monitoring in patients with inflammatory bowel disease treated with azathioprine therapy: a Chinese healthcare perspective using real-world data.

Authors:  Dayong Zeng; Xiaoting Huang; Shen Lin; Rongfang Lin; Xiuhua Weng; Pinfang Huang
Journal:  Ann Transl Med       Date:  2021-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.